Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics [Internet]. 2019 Oct. 9 [cited 2024 Apr. 28];74:e1517. Available from: https://revistas.usp.br/clinics/article/view/163040